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An AgNPs solution was synthesized by chemical reduction, characterized, and tested against Candida glabrata, Candida tropicalis,
Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus (MRSA). Minimum inhibitory (MICs) and minimum
fungicidal/bactericidal concentrations (MFC/MBC) were determined on planktonic cells. Also, total biofilmmass was determined
by crystal violet (CV) staining and morphological changes by scanning electron microscope (SEM). MICs for C. glabrata, C.
tropicalis, S. aureus, and MRSA were 15.63, 3.91, 1.95, and 1.95 𝜇g/mL, respectively. MFC for C. glabrata was 62.5 𝜇g/mL and for
C. tropicalis 15.63 𝜇g/mL The same MBC (3.91 𝜇g/mL) was observed for S. aureus and MRSA. CV assay showed that the AgNPs
(1000𝜇g/mL) promoted reductions in biofilm mass of ∼60% for C. glabrata and ∼35% for C. tropicalis. A reduction of ∼20% in
C. tropicalis biomass was also observed at the concentration of 3.91𝜇g/mL. No significant effect on total biomass was found for S.
aureus and MRSA. SEM images revealed that C. glabrata and C. tropicalis biofilm cells, exposed to the AgNPs (1000𝜇g/mL), had
an irregular and shriveled appearance. AgNPs solution exhibited considerable antimicrobial activity against important fungal and
bacterial pathogens, associated with several oral and systemic diseases, and has potential as an antimicrobial agent.
1. Introduction
The oral cavity contains numerous types of microorganisms
[1] that have the ability to attach to both biotic and abiotic
surfaces, such as the denture base materials. Glass et al.
[2] evaluated the spectra of microorganisms residing on the
surfaces and depths of complete maxillary and mandibular
dentures. A total of 2292 isolates were obtained from the
dentures, among them Candida albicans, Candida glabrata,
Candida tropicalis, Staphylococcus aureus, and Streptococcus
pneumoniae. Denture surfaces and the oral cavity have also
been reported as important reservoirs ofmethicillin-resistant
Staphylococcus aureus (MRSA), a strain of S. aureus that is
highly resistant to many antibiotics [3, 4]. This resistance
is associated with the gene mecA, which encodes an extra
penicillin-binding protein (PBP2A). This protein, due to its
extremely low affinity to all 𝛽-lactam antibiotics, provides
the transpeptidase activity, which is essential to the cell wall
peptidoglycan synthesis [4].
Oral microorganisms can cause local infections such as
Candida-associated denture stomatitis that may affect 65% to
80% of denture patients [2]. Despite the fact that one of the
main etiological factors of this disease is C. albicans, other
species, such asC. glabrata,C lusitaniae,C parapsilosis, andC.
tropicalis [2, 5], may also be involved. C. glabrata represents
the second most prevalent fungal pathogen and exhibits
innate resistance to azole-based drugs, and, for C. tropicalis,
acquired resistance to these drugs has also been reported [6].
In addition to the local disease, Candida may penetrate the
epithelium and invade the host tissues, resulting in systemic
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infections. Invasive candidiasis (the invasion of Candida
spp. in a human organ) and candidemia (invasion via the
bloodstream) have shown an increasing incidence in the
nosocomial setting [7]. AlthoughC. albicans ranks first in iso-
lation frequency of candidemia [8], the non-albicans species
C. tropicalis and C. glabrata have been isolated in blood
cultures [9]. Bacterial species (Staphylococcus epidermidis,
Enterococcus spp., and S. aureus) were also coisolated from
372 patients with candidemia [10]. In addition, C. albicans
may serve as a scaffold for the attachment of S. aureus, which
is considered one of themost pathogenic humanbacteria, and
also contribute to its vancomycin resistance [11].
Systemic infections are difficult to treat and the mortality
for invasive candidiasis and candidemia ranges between 36%
and 63% depending on patient population [7]. Bacteremia
due to MRSA has also been associated with increased
mortality compared with methicillin-susceptible S. aureus
bacteremia [12]. Gasch et al. [13] evaluated 579 episodes of
MRSA bloodstream infection and reported that mortality
was observed in 179 (32%) episodes. Thus, the occurrence
of these systemic infections has become an important and
growing public health problem worldwide and the develop-
ment of new antimicrobial agents is needed. In this context,
nanotechnology has contributed significantly to advances in
health research and nanoparticles have attracted great sci-
entific interest, particularly silver-containing nanoparticles
(AgNPs). Because AgNPs use multiple mechanisms to kill
and/or inhibit growth of microorganisms, they represent one
of the most promising strategies for overcoming microbial
resistance [14]. It has been reported that AgNPs are efficient
antimicrobial agents against the growth of a broad spectrum
of bacterial and fungal species [15–22]. In our previous study
[23], an AgNPs solution was synthesized by chemical reduc-
tion method and characterized, and its activity against C.
albicans was demonstrated. In this investigation, the biocidal
action of the AgNPs solution against other important fungal
(C. glabrata and C. tropicalis) and bacterial (S. aureus and
MRSA) pathogens was further evaluated. The antibacterial
properties of the AgNPs solution were investigated against
both planktonic (free-floating) cells and biofilms.
2. Materials and Methods
2.1. Preparation and Characterization of AgNPs Solution.
The AgNPs solution was synthesized by chemical reduction
method and characterized as described in our previous
publication [23]. Briefly, silver nitrate (AgNO
3
, 90mgmL−1)
was reduced by sodium borohydride (NaBH
4
, 540mgmL−1)
in the presence of PVA (230mgmL−1), and the molar ratio of
AgNO
3
to PVA was maintained at 1 : 4. An absorption band
at around 400 nm was observed in the UV-vis spectra of the
solution, indicating the presence of spherical AgNPs [23].
The presence of PVA, which was used as the stabilizing agent
to prevent agglomeration of nanoparticles, was confirmed
in the FTIR spectra [23]. Broadening in the band from OH
(3200–3400 cm−1) and a significant decrease in the band
at 840 cm−1 (out-of-plane CH vibration in PVA) suggested
interactions between Ag and the OH groups from PVA.
Absence of the band at about 1596 cm−1 indicated that the
AgNPs influenced the vibration of the atoms of the polymer
chains. The nanoparticles size was 𝑐. 9 nm, as determined by
the DLS analysis [23].
2.2. Microbial Strains and Growth Conditions. Candida gla-
brata (ATCC 2001), Candida tropicalis (ATCC 4563), Sta-
phylococcus aureus (ATCC 25923), and MRSA (ATCC 33591)
were used in this study. The bacterial and fungal stock
cultures were maintained at −70∘C. During the experimental
period, the microorganisms were maintained at 4–6∘C, in
appropriate medium (Sabouraud dextrose agar, SDA, for C.
glabrata and C. tropicalis, and mannitol salt agar were for S.
aureus and MRSA). Prior to MIC, MFC, and MBC testing,
a loopful of each stock culture was streaked onto SDA (C.
glabrata and C. tropicalis) or mannitol salt agar (S. aureus
and MRSA) and incubated at 37∘C for 48 h. From these
young cultures, one loopful was transferred to 20mL of yeast
nitrogen base (YNB) medium with 50mmol−1 glucose for
the Candida cells or to tryptic soybean broth (TSB) medium
for the S. aureus and MRSA cells and incubated at 37∘C for
24 h, respectively. Yeast and bacteria cells of the resultant
cultures were harvested and washed twice with phosphate
buffered saline (PBS) (pH 7) at 3220 g for 5min. Then, yeast
and bacteria cells were resuspended in RPMI-1640 and TSB
culture medium, respectively.
2.3. The In Vitro Antimicrobial Activity of the Synthe-
sized AgNPs Solution. The antimicrobial activity of the
AgNPs was evaluated against planktonic microbial strains
by determining the minimum inhibitory concentrations
(MICs) andminimum fungicidal/bactericidal concentrations
(MFC/MBC). MIC and MBC/MFC were determined using
96-well microtiter plates, according to the microdilution
method of the Clinical and Laboratory Standards Institute
(CLSI) (document M27-A3, 2008, and document M7-A7,
2006) [24] with some modifications. For Candida spp., each
well contained the microorganism at a final concentration
of 2.5 × 103 cells/mL, RPMI-1640 culture medium, and the
AgNPs solution. For bacteria, each well contained the cells
at a final concentration of 2.5 × 105 cells/mL, TSB culture
medium, and the AgNP solution. Inoculated RPMI-1640
or TSB culture medium (without the AgNPs solution) was
included as positive control and uninoculated RPMI-1640 or
TSB culture medium as negative control. The MIC values
were determined by incubating for 24 h (S. aureus and
MRSA) or 48 h (Candida spp.) at 37∘C, exposed to serial 2-
fold dilution in RPMI-1640 or in TSB culture medium of
the AgNPs solution (from 1000 to 1.95 𝜇gmL−1). The MICs
were defined as the lowest concentrations showing no growth
by visual inspection. To establish MFC/MBC, aliquots from
each well were removed and diluted serially 10-fold, and each
dilution was plated, in duplicate, on SDA (for yeast) and
mannitol salt agar (for bacteria). After 48 h of incubation
at 37∘C, the colony-forming units per millilitre (CFU mL−1)
were then determined. The MFC/MBC values were defined
as the lowest concentration of the AgNPs solution resulting
in no growth. These assays were performed in triplicate on
three different occasions.
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The influence of the AgNPs solution on the microbial
biofilms was also evaluated by using the absorbance of the
crystal violet staining to determine the total biomass of the
biofilms. For this purpose, mature 48 h biofilms of Candida
spp. and bacteria were formed in 96-well microtiter plates
with suspensions of each microorganism spectrophotomet-
rically standardized to 1 × 107 cellsmL−1 in their respective
culture media. In this study, tryptic soy broth medium
(TSB, Acumedia Manufacturers, Inc., Baltimore, Maryland,
EUA) was used to grow Staphylococcus aureus biofilms, while
RPMI-1640 medium was used to grow Candida biofilms.
The cell suspensions were placed into each well and incu-
bated at 37∘C in an orbital shaker at 75 rpm. After 90min
(adhesion phase), the loosely adhered cells were removed
by washing twice with 200𝜇L of PBS to remove nonad-
herent cells. Wells were then filled with 200 𝜇L of culture
medium according to each microorganism, and the plates
were incubated (37∘C; 75 rpm) for 48 h. One hundred micro-
liters of culture media were renewed after 24 h. Following
biofilm formation (48 h), the medium was aspirated and
nonadherent cells were removed by washing with 200 𝜇L
of PBS. Culture media according to each microorganism
(200𝜇L) containing different concentrations (from 1000 to
1.95 𝜇gmL−1) of the AgNPs solution were then added to
the preformed biofilms and maintained for 24 h. Biofilms
incubated only with respective culture media were positive
controls, while negative controls were wells containing only
medium (without biofilms). To determine the total biomass,
the biofilms were fixed with methanol and stained with
1% violet crystal solution for 5min. The stain bonded to
biofilms was dissolved in acetic acid at 33% and the optical
density was measured (570 nm) using a spectrophotometer
(Thermo Plate—TP Reader). These assays were performed
in quadruplicate on two different occasions. Data obtained
from total biomass were statistically analyzed byANOVA and
Tukey post hoc tests at 5% of significance.
2.4. Scanning Electron Microscopy. A scanning electron
microscope (SEM) (JEOL JSM 6610LV) was used to observe
the morphological changes of the microorganisms caused by
AgNPs. For such purpose, the bottom of each well of the
12-well polystyrene plates, where the biofilms were formed,
was extracted from the plate. The nonadherent cells were
removed by washing in PBS and the cells were fixed in 2.5%
glutaraldehyde for 24 hours at room temperature. Thereafter,
they were dehydrated through a graded ethanol series (70, 85,
90, and 100%).Then, the sample from each groupwas sputter-
coated with carbon.
3. Results
PlanktonicMIC values for C. glabrata, C. tropicalis, S. aureus,
andMRSAwere 15.63, 3.91, 1.95, and 1.95 𝜇g/mL, respectively.
The MFC of the AgNPs solution for planktonic C. glabrata
was 62.5 𝜇g/mL and for C. tropicalis 15.63 𝜇g/mL.The AgNPs
solution also exhibited bactericidal effect against S. aureus
and MRSA, with the same MBC value (3.91 𝜇g/mL).
Results from the crystal violet assay (Figures 1 and 2)
showed that the total biomass of C. glabrata was significantly
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Figure 1: Absorbance values (570 nm) obtained with crystal violet
staining assay for Candida glabrata and Candida tropicalis biofilms
treated with different AgNps concentrations. Error bars are standard
deviations.
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Figure 2: Absorbance values (570 nm) obtained with crystal violet
staining assay for MRSA and Staphylococcus aureus biofilms treated
with different AgNps concentrations. Error bars are standard devia-
tions.
decreased by the AgNPs solution at a concentration of
1000 𝜇g/mL compared to control (biofilm without AgNPs).
For C. tropicalis, the AgNPs solution promoted a significant
biomass reduction at concentrations greater than 3.91 𝜇g/mL.
The synthesized AgNPs solution had no significant effect on
the total biomass for the bacterial strains evaluated (MRSA
and S. aureus).
SEM analysis showed that, after exposure to the AgNPs
(white arrowheads), the C. glabrata and C. tropicalis biofilm
cells had an irregular and shriveled appearance (white
arrows). Figures 3(a) and 3(b) are representative images of
typical fields of view for C. glabrata and C. tropicalis exposed
to the highest AgNPs concentration evaluated (1000𝜇g/mL).
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Figure 3: SEM analysis. (a) and (b) are representative images of typical fields of view for C. glabrata and C. tropicalis exposed to the highest
AgNPs concentration evaluated (1000𝜇g/mL).
4. Discussion
Several new antimicrobial agents have been developed and
investigated for their efficacy in inactivating clinically impor-
tant pathogenic bacteria and fungi. In this context, silver,
which is known for its antimicrobial property, has been
evaluated recently in the form of nanoparticles. Compared
to bulk materials, silver nanoparticles have a higher surface
area tomass ratio, which provides notable physical, chemical,
and biological properties [25]. The smaller the particle size,
the higher the active or specific surface area to come in
contact with the microbial cells, increasing the interaction
and penetration into the cell membrane and, consequently,
their antimicrobial activity [16, 25–27]. Furthermore, the type
of molecule that stabilizes the nanoparticles may influence
the activity, with polyvinyl alcohol (PVA) stabilized silver
nanoparticles showing higher antibacterial properties against
Escherichia coli, Staphylococcus aureus, and Pseudomonas
aeruginosa than polyvinylpyrrolidone (PVP) stabilized ones
[28]. In addition, PVA has some advantages, such as easy pro-
cessability, high transmittance, and water solubility [29].
Among the methods to synthesize silver nanoparticles, the
chemical reduction of a silver salt solution by a reducing
agent such as borohydrate (NaBH
4
) is commonly used [17],
due to simple operation, easily controlled reaction condi-
tions, high reaction rate, and low cost. Hence, in this study,
an AgNPs solution was synthesized by chemical reduction
method described in our previous report [23], using boro-
hydrate (NaBH
4
) as the reducing agent and PVA to prevent
agglomeration of the nanoparticles, whose size was 𝑐. 9 nm.
This solution was further used to determine its antimicro-
bial activity against representative microbial species such as
Gram-positive bacteria and fungi.
The results from the microbiological tests demonstrated
that the synthesized AgNPs solution was not only fungistatic
but also fungicidal for C. glabrata and C. tropicalis. Similarly,
the synthesized AgNPs were capable of inhibiting the growth
and also of killing the S. aureus and MRSA planktonic cells,
regardless of the antibiotic susceptibility profile of these
bacteria.The antimicrobial activity of silver nanoparticles has
been attributed to different mechanisms [30], such as direct
physical contact between the nanoparticles and the microor-
ganism causing structural damage [15, 18], the generation of
reactive oxygen species (ROS) damaging the membrane [18],
and the slow release of silver ions which interfere with the
DNA replication and inhibit enzymes by reacting with thiol
groups [16]. These findings suggest that the activity of the
AgNPs solution against the bacteria and fungi observed in
this study was probably due to the destruction of membrane
integrity. The small size of the synthesized AgNPs may
also have accounted for their antimicrobial efficiency [16, 25–
27].
In a previous study [23], MIC and MFC values for C.
albicanswere the same as those observed here forC. tropicalis
(3.98 𝜇g/mL and 15.63𝜇g/mL, resp.), indicating that both
species were more sensitive to the synthesized AgNPs than
C. glabrata, whose MIC/MFC values were 15.63 𝜇g/mL and
62.5 𝜇g/mL, respectively. Hence, the antimicrobial activity of
AgNPs was affected by the characteristics of the microbial
species, such as the cell wall, which may have played a role.
Electron microscopy of C. glabrata cells showed that they
were surrounded by a 100- to 200-nm-thick double wall,
which contains the same basic components as those inC. albi-
cans (1,3-𝛽-glucan, 1,6-𝛽-glucan, chitin, and mannoproteins)
[31]. However, the contribution of individual components
and the extent of cross-links between the components are
different. The mannose/glucose ratio is higher in C. glabrata
than in C. albicans. Moreover, the amount of alkali-insoluble
glucans, relative to both total wall mass and total glucan,
is lower than those in C. albicans, suggesting that there
are fewer cross-links between glucan and chitin in the cell
wall of C. glabrata [31]. Although there is less information
available on C. tropicalis, electron micrographs also have
shown yeast cells presenting a compact, double cell wall
(average thickness of 0.13 𝜇m) [32], with an outer layer with
high electron density and an inner layer with less electron
density [33].Therefore, since the cell walls of pathogenic fungi
form the first point of contact with the environment, these
differences in architecture and components among Candida
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species probably may have contributed to the higher MIC
and MFC values observed for planktonic C. glabrata cells
compared to C. tropicalis and C. albicans cells.
The composition and structural differences of cell wall
may also have caused the bacteria S. aureus and MRSA to
be more sensitive (MIC 1.95 𝜇g/mL and MBC 3.91 𝜇g/mL,
for both strains) to the synthesized AgNPs than the fungi.
The cell wall in Gram-positive bacteria, such as S. aureus and
MRSA, is of a single layer, mainly consisting of a peptidogly-
can chain of polysaccharide, teichoic acid, and phosphated
sugar [34]. In addition, the outer membrane is absent.
Because the outer membrane indirectly helps stabilize the
inner membrane, the peptidoglycan mesh surrounding
Gram-negative cells is relatively thinwith only a few nanome-
ters thick, while Gram-positive microorganisms are sur-
rounded by many layers of peptidoglycan with 30–100 nm
thickness [35]. Despite this thicker and more compact pep-
tidoglycan layer of Gram-positive bacteria, with a three-
dimensional rigid structure, it is likely that the bilayered
structure of the cell wall of Candida species played an impor-
tant role in its resistance to the AgNps. Another characteristic
that may have contributed to these results is the size of the
microorganisms. Candida species are eukaryotic cells, while
S. aureus and MRSA are prokaryotic cells, and therefore the
fungal cell is significantly larger than the bacterial cells [36]
and thus required a higher AgNPs solution concentration
to be inactivated. However, others have observed a different
rank order of antifungal activity of AgNPs againstC. glabrata,
C. tropicalis, and C. albicans [20, 28, 37]. The dissimilar find-
ings among studies suggest that the antimicrobial effect of Ag
nanoparticlesmay be not solely dependent on the component
and structure of the microbial cell wall but also dependent
on the nanoparticles characteristics, such as size and shape,
which are known to be affected by the synthesis method
used.
The influence of the AgNPs solution on biofilms of each
of the four microorganisms was also evaluated. In biofilms,
the cells are fixed at a surface and embedded in a self-
produced extracellular polymeric substance (EPS) matrix.
In this study, the assay used was the crystal violet, which
stains the bacteria as well as the biofilm EPS components,
thus quantifying the total biofilmmass.The results confirmed
that, when organized in biofilms, the microorganisms are
more tolerant to antimicrobial agents. For C. glabrata, a
∼60% decrease in biofilm mass was observed when the
biofilm was treated with 1000 𝜇g/mL of the synthesized
AgNPs. In the case of C. tropicalis, a reduction of ∼20%
was observed at the concentration of 3.91 𝜇g/mL, and ∼35%
decrease in biofilm mass was seen at the higher concen-
tration (1000 𝜇g/mL). Corroborating with these findings are
SEM images of biofilms treated with the AgNPs solution:
C. glabrata and C. tropicalis cells displayed morphological
changes with shriveled cell walls and were collapsed to
some extent. These alterations may have impaired the matrix
production. Greater effect of silver nanoparticles on reducing
C. glabrata biofilm biomass compared with other Candida
species, as C. albicans, has also been found [21]. The AgNPs
solution did not promote a significant biomass reduction for
both MRSA and S. aureus biofilms. Similar findings were
reported by Martinez-Gutierrez [22], who observed high
resistance of established biofilm of MRSA to the action of the
AgNPs.
Differences in the matrix components between the bac-
terial and the fungal biofilms evaluated in this study may
have accounted for the less effective activity of the AgNPs
solution against MRSA and S. aureus. The differences may
also have accounted for a lower percentage of decrease in
biofilm mass observed here for C. tropicalis when compared
to C. glabrata biofilms. Costa et al. [38] reported that C.
glabrata forms a thin, compact biofilm consisting of yeast
cells embedded in an extracellular matrix, while Candida
tropicalis develops a complex biofilm structure that contains
coaggregated microcolonies of blastoconidia and a thick
extracellular polymeric layer. With regard to the matrix com-
position,C. glabrata biofilms have relatively higher quantities
of both protein and carbohydrate comparedwithC. tropicalis;
however, the total biomass is lower in C. glabrata biofilms
[39]. In addition, C. tropicalis biofilm matrix consists mainly
of hexosamine in the form of a polysaccharide like that found
in Staphylococcal biofilms. This polysaccharide is sometimes
referred to as the intercellular polysaccharide adhesin (PIA)
and has been associated with the lower susceptibility of C.
tropicalis biofilms to the antifungal agents [40]. A review by
Boles andHorswill [41] reported that, besides PIA, the second
major biofilm matrix components of Staphylococcal biofilms
are proteins, such as the fibronectin binding proteins, protein
A, SasG, and beta toxin. eDNA is another recently described
component, which is thought to serve a structural role in the
S. aureus biofilm matrix [41].
5. Conclusion
In this study, an AgNPs solution, synthesized using a chem-
ical reduction method, was tested against fungi (C. glabrata
and C. tropicalis) and bacteria (S. aureus andMRSA). Differ-
ent degrees of sensitivity were shown among themicroorgan-
isms, probably due to the differences in the structure and/or
composition of their cell walls and extracellular matrix.
Nevertheless, the synthesized AgNPs showed considerable
activity against planktonic S. aureus, MRSA, C. glabrata, C.
tropicalis, and also C. albicans, as reported previously [23].
Reductions in total biomass of mature biofilms of C. glabrata
and C. tropicalis were also achieved. These microorganisms
are important human pathogens and have been associated
with several oral and systemic diseases.The fact that prepara-
tionmethod of the AgNPs used here is easy and cost-effective
is also of importance. Thus, the synthesized AgNPs solution
has potential as an antifungal agent, warranting further
investigations on methods that allow the nanoparticles to
more efficiently penetrate the biofilm and interact with the
targeted microorganisms. From the SEM analysis, it could
be observed that when this interaction occurred, the AgNPs
were able to cause membrane damage.
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